US OptionsDetailed Quotes
ASRT250117P1000
- 0.10
- 0.000.00%
15min DelayClose Jan 3 16:00 ET
0.00High0.00Low
0.10Open0.10Pre Close0 Volume4.36K Open Interest1.00Strike Price0.00Turnover156.27%IV-1.81%PremiumJan 17, 2025Expiry Date0.12Intrinsic Value100Multiplier12DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6077Delta1.4991Gamma5.05Leverage Ratio-0.0039Theta-0.0002Rho-3.07Eff Leverage0.0006Vega
Assertio Stock Discussion
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
Friday, 13th December at 8:00 am
LAKE FOREST, Ill., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced yesterday results of a clinical trial investigating the utility of Rolvedon® (eflapegrastim-x...
Underated/Valued, overlooked, great buy!!!
This one is killin it....
No comment yet